… Annual Meeting demonstrated that, relative to ARBs, ACE inhibition confers a significant (p
= 0.01) … The role of ACE inhibitors in the treatment of hypertension and in the prevention and …

… that inhibition of the RAS with an ACE-I perindopril will result in secondary prevention of
coronary … The ACE-I perindopril in EUROPA [9] significantly reduced the combined endpoint of …

… of secondary prevention, tailored to include maximum cholesterol reduction, BP and glycaemic
control, ACE inhibition … recent information from large secondary prevention trials, eg the …

… secondary prevention of CVD may help clarify this issue. The objective of this meta-analysis
is to evaluate the association between antihypertensive treatment and secondary prevention …

… In summary, these HOPE findings support the use of ACE inhibition to prevent cardiovascular
complications in patients with type 2 diabetes with or without concomitant renal disease. …

… The evidence is, therefore, strong for ACE inhibitors being pivotal to the primary and
secondary prevention of cardiovascular disease across a broad range of “high-risk” individuals …

… We analysed use of antiplatelet drugs, β blockers, ACE inhibitors or ARBs, statin, and
diuretics (because of recognised benefit after stroke). We included β blockers, ACE inhibitors or …

… of ACE, renin, renin angiotensin system (circulating vs local RAS), mechanism of ACE
inhibitors, and development of ACE inhibitors. … ACE inhibitors prevent the progression of renal …

… Although ongoing trials 31 are addressing the issue of long-term secondary prevention with
ACE inhibitors in patients at high risk of vascular events, no other placebo-controlled trials in …

… However, there was an increased risk of stroke outcomes for ACE inhibitors compared
with … cardiovascular outcomes and the ACE inhibitor group had higher stroke mortality risk. …